SG Americas Securities’s Procept Biorobotics PRCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$374K Sell
16,569
-17,147
-51% -$429K ﹤0.01% 2475
2026
Q1
$843K Sell
33,716
-50,578
-60% -$1.43M ﹤0.01% 1878
2025
Q4
$2.65M Buy
84,294
+49,457
+142% +$1.64M ﹤0.01% 1376
2025
Q3
$1.24M Buy
34,837
+32,787
+1,599% +$1.5M ﹤0.01% 1266
2025
Q2
$118K Buy
+2,050
New +$116K ﹤0.01% 2564
2025
Q1
Sell
-6,598
Closed -$531K 3691
2024
Q4
$531K Buy
6,598
+4,931
+296% +$421K ﹤0.01% 1288
2024
Q3
$134K Sell
1,667
-57
-3% -$4.05K ﹤0.01% 2822
2024
Q2
$105K Sell
1,724
-8,043
-82% -$478K ﹤0.01% 2524
2024
Q1
$483K Sell
9,767
-2,106
-18% -$100K ﹤0.01% 1444
2023
Q4
$498K Buy
11,873
+8,526
+255% +$290K ﹤0.01% 1489
2023
Q3
$110K Sell
3,347
-8,450
-72% -$288K ﹤0.01% 2732
2023
Q2
$417K Buy
11,797
+7,277
+161% +$241K ﹤0.01% 1485
2023
Q1
$128K Buy
4,520
+527
+13% +$18.6K ﹤0.01% 2750
2022
Q4
$166K Buy
+3,993
New +$171K ﹤0.01% 2337

Other funds holding PRCT

SG Americas Securities's PRCT Position: Q2 2026 in Review

SG Americas Securities reduced its Procept Biorobotics (PRCT) stake by 51% in Q2 2026, selling an estimated $429K and leaving 16,569 shares worth $374K. The position accounts for ﹤0.01% of the portfolio, ranked #2475.

SG Americas Securities first reported a position in PRCT in Q4 2022 and has held it in 14 quarters since. The position peaked at $2.65M in Q4 2025. 254 funds tracked by Wall St. Rank hold PRCT as of Q2 2026.

  • SG Americas Securities held 16,569 shares of Procept Biorobotics worth $374K as of Q2 2026.
  • SG Americas Securities sold 17,147 Procept Biorobotics shares in Q2 2026, an estimated $429K.
  • Procept Biorobotics made up ﹤0.01% of SG Americas Securities's portfolio in Q2 2026, its #2475 holding.
  • SG Americas Securities first reported a position in Procept Biorobotics in Q4 2022 and has held it in 14 quarters since.
  • SG Americas Securities's Procept Biorobotics position peaked at $2.65M in Q4 2025.
  • 254 funds tracked by Wall St. Rank held Procept Biorobotics as of Q2 2026.

Based on SG Americas Securities's 13F filing for Q2 2026, filed 7 Aug 2026.